Nautilus Biotechnology, Inc. (NAUT) Stock

Nautilus Biotechnology, Inc. (NAUT) is a Technology stock trading at $0.90 (as of 2026-08-20), with a market capitalization of $114.35M. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Nautilus Biotechnology, Inc. is a development-stage life sciences company developing platform technology for measuring and analyzing the proteome. Its Nautilus Platform provides an end-to-end solution that includes instruments, consumables, and software analysis for proteomics workflows.

Valuation — source: SEC EDGAR (first-party)
Price$0.90
Market Cap$114.35M
Price / Book0.79
FCF Yield-46.3%
Valuation vs Sector & Industry
Sector P/E (Technology)33.9
Industry P/E (Measuring & Control Equipment)51.8
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional Holdera16z Capital Management, L.L.C. ($68.50M)
Institutional Holders Tracked10
Company
SectorTechnology
IndustryMeasuring & Control Equipment
CEOSujal Patel
Employees134
CountryUS
IPO Date2020-08-07

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Cytek Biosciences, Inc. (CTKB)
  • Pacific Biosciences of California, Inc. (PACB)
  • Harvard Bioscience, Inc. (HBIO)
  • Quanterix Corporation (QTRX)
  • Seer, Inc. (SEER)
  • Rapid Micro Biosystems, Inc. (RPID)
  • Precipio, Inc. (PRPO)
  • Astrotech Corporation (ASTC)
NAUT earnings history · NAUT institutional & insider holders · NAUT KPIs & operating metrics · NAUT financials · NAUT investor presentations & press releases · NAUT SEC filings · NAUT peers · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-08-20.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.